Lessard S, Rimmele P, Ling H, Moran K, Vieira B, Lin Y
Sci Rep. 2024; 14(1):24298.
PMID: 39414860
PMC: 11484757.
DOI: 10.1038/s41598-024-74716-7.
Rakshak R, Bhatt S, Sharma S, Agharkar R, Bodakhe S, Srivastava R
Nanotheranostics. 2024; 8(3):330-343.
PMID: 38577323
PMC: 10988212.
DOI: 10.7150/ntno.93206.
Palomarez A, Jha M, Medina Romero X, Horton R
Biophys Rev (Melville). 2024; 3(3):031302.
PMID: 38505276
PMC: 10903381.
DOI: 10.1063/5.0094650.
Nolfi-Donegan D, Annarapu G, St Croix C, Calderon M, Hillery C, Shiva S
JCI Insight. 2024; 9(5).
PMID: 38456510
PMC: 10972595.
DOI: 10.1172/jci.insight.174575.
Kumari N, Ahmad A, Berto-Junior C, Ivanov A, Wen F, Lin X
iScience. 2024; 27(2):108813.
PMID: 38318349
PMC: 10839265.
DOI: 10.1016/j.isci.2024.108813.
Overview of the Association Between the Pathophysiology, Types, and Management of Sickle Cell Disease and Stroke.
Hakami F, Alhazmi E, Busayli W, Althurwi S, Darraj A, Alamir M
Cureus. 2023; 15(12):e50577.
PMID: 38107212
PMC: 10723021.
DOI: 10.7759/cureus.50577.
Using disease-modifying therapies in sickle cell disease.
Rai P, Ataga K
Hematology Am Soc Hematol Educ Program. 2023; 2023(1):519-531.
PMID: 38066905
PMC: 10727073.
DOI: 10.1182/hematology.2023000485.
Natural history of blood pressure in sickle cell disease pregnancy.
Early M, Luo A, Solow M, Matusiak K, Eke A, Shehata N
Br J Haematol. 2023; 204(2):658-667.
PMID: 37803527
PMC: 10903988.
DOI: 10.1111/bjh.19133.
Impact of Imatinib on reducing the painful crisis in patients with sickle cell disease.
Karimi M, Bahadoram M, Mafakher L, Rastegar M
Hematol Transfus Cell Ther. 2023; 46(4):387-392.
PMID: 37652804
PMC: 11451392.
DOI: 10.1016/j.htct.2023.06.007.
The APC-EPCR-PAR1 axis in sickle cell disease.
Ramadas N, Sparkenbaugh E
Front Med (Lausanne). 2023; 10:1141020.
PMID: 37497271
PMC: 10366386.
DOI: 10.3389/fmed.2023.1141020.
Descending Facilitation of Nociceptive Transmission From the Rostral Ventromedial Medulla Contributes to Hyperalgesia in Mice with Sickle Cell Disease.
Rogness V, Juliette J, Khasabova I, Gupta K, Khasabov S, Simone D
Neuroscience. 2023; 526:1-12.
PMID: 37330194
PMC: 10528639.
DOI: 10.1016/j.neuroscience.2023.06.007.
Flurbiprofen inhibits heme induced NLRP3 inflammasome in Berkeley sickle cell disease mice.
Kour D, Ali M, Khajuria P, Sharma K, Ghosh P, Kaur S
Front Pharmacol. 2023; 14:1123734.
PMID: 37180702
PMC: 10171431.
DOI: 10.3389/fphar.2023.1123734.
Clinical and laboratory differences between pediatric hospitalized patients with sickle cell disease infected or not by SARS-CoV-2.
Elia G, Konstantyner T, Nais R, Dos Santos A, Angel A, Braga J
Rev Paul Pediatr. 2023; 41:e2021407.
PMID: 36921171
PMC: 10013992.
DOI: 10.1590/1984-0462/2023/41/2021407.
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.
Sparkenbaugh E, Henderson M, Miller-Awe M, Abrams C, Ilich A, Trebak F
Blood. 2023; 141(15):1871-1883.
PMID: 36706361
PMC: 10122107.
DOI: 10.1182/blood.2022017074.
Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease.
Fitzhugh C
Hematology Am Soc Hematol Educ Program. 2022; 2022(1):266-271.
PMID: 36485129
PMC: 9820448.
DOI: 10.1182/hematology.2022000371.
Neutrophils as drivers of vascular injury in sickle cell disease.
Torres L, Hidalgo A
Immunol Rev. 2022; 314(1):302-312.
PMID: 36251624
PMC: 10132504.
DOI: 10.1111/imr.13146.
Recent advances in "sickle and niche" research - Tribute to Dr. Paul S Frenette.
Torres L, Asada N, Weiss M, Trumpp A, Suda T, Scadden D
Stem Cell Reports. 2022; 17(7):1509-1535.
PMID: 35830837
PMC: 9287685.
DOI: 10.1016/j.stemcr.2022.06.004.
Development and validation of the sickle cell stress scale-adult.
Smith W, McClish D, Bovbjerg V, Singh H
Eur J Haematol. 2022; 109(3):215-225.
PMID: 35585659
PMC: 9531901.
DOI: 10.1111/ejh.13789.
Anaesthetic management of patients with sickle cell disease in obstetrics.
Stoddard K, Sohal M, Bedson R
BJA Educ. 2022; 22(3):87-93.
PMID: 35211325
PMC: 8847837.
DOI: 10.1016/j.bjae.2021.11.005.
Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome.
Jutant E, Voiriot G, Labbe V, Savale L, Mokrani H, Van Dreden P
ERJ Open Res. 2021; 7(4).
PMID: 34912886
PMC: 8666627.
DOI: 10.1183/23120541.00496-2021.